Safety and efficacy of tandem <sup>131</sup>I‐metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma
Kelsey E. Johnson(University of Southern California), Yaël P. Mossé(Children's Hospital of Philadelphia), Barbara McGlynn(Children's Hospital of Philadelphia), Diane Baniewicz(Children's Hospital of Philadelphia), Hongming Zhuang(Children's Hospital of Philadelphia), Jennifer Saggio(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia)
Cited by 61
Related Papers
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study
|PLoS Medicine|2020|131
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
|Nature Medicine|2023|125
The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
|Clinical Cancer Research|2021|119